Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Одесский Национальный Медицинский УниверситетfiledCriticalОдесский Национальный Медицинский Университет
Priority to UAU201309481UpriorityCriticalpatent/UA86855U/en
Publication of UA86855UpublicationCriticalpatent/UA86855U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The method for treating the infectious mononucleosis provides for the use of the inducer of endogenous interferon and Amixin IC at a dose of for two consecutive days in a week for 5 weeks. After one month pause, the course of Amixin IC is repeated. Furthermore, in first 10-12 days of the treatment, Valcyk is used at a dose of 500 mg twice a day.
UAU201309481U2013-07-292013-07-29Method for treating infectious mononucleosis
UA86855U
(en)